Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS??? DEFICIT (Details Narrative)

v3.23.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)
 3 Months Ended
Oct. 10, 2022
Oct. 22, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Preferred stock shares, authorized     10,000,000   10,000,000
Preferred stock, par or stated value per share     $ 0.0001   $ 0.0001
Preferred stock shares issued     0   0
Preferred stock shares outstanding     0   0
Common stock shares authorized     1,000,000,000   1,000,000,000
Common stock par value     $ 0.0001   $ 0.0001
Common stock shares outstanding     42,804,825   38,263,813
Restricted stock $ 50,000        
Number of securities called by warrants     9,082,024    
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right     15,806    
Convertible Promissory Note [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of securities called by warrants   450,000      
Debt maturity date, description   October 20, 2021 to October 20, 2022.      
Stock issued during period shares   450,000      
Proceeds from issuance of common stock   $ 197,501      
Term of warrants   5 years      
Exercise price of warrants per share   $ 1.00      
Other expenses     $ 0 $ 48,699  
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of securities called by warrants     4,541,012